# Expanded Access to Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrent Prostate Cancer

> **NCT05415228** · — · NO_LONGER_AVAILABLE · sponsor: **Morand Piert, MD**

## Conditions studied

- Prostate Adenocarcinoma

## Interventions

- **DRUG:** 68Ga-PSMA-11

## Key facts

- **NCT ID:** NCT05415228
- **Lead sponsor:** Morand Piert, MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2023-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05415228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05415228, "Expanded Access to Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrent Prostate Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05415228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*